Hypoparathyroidism: an uncommon adverse effect of treatment with durvalumab
{{output}}
Summary: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies approved for the treatment of numerous cancer types. Toxicities induced by ICIs may affect any organ system and manifest as endocrinopathy. The main side effe... ...
